522  International  Pharmaceutical  Congress,  {^^'oct'^^^i'^^ 
Denmark. — The  present  pharmacopogia,  which  is  13  years  old,  was  pre- 
pared by  a  commission  consisting  of  eight  physicians  and  two  pliarmacists. 
On  resuming  business  after  luncheon  Mr.  Thomas  Greenish  took  the 
chair,  and  explained  tlae  foundation  of  the  Hanbury  Medal.,  in  memory  of 
the  late  Daniel  Hanbury.    He  continued: 
It  was  resolved  that  tlie  medal  should  be  awarded  "for  high  excellence 
in  the  prosecution  and  promotion  of  original  research  in  the  natural  his- 
tory and  chemistry  of  drugs,"  and  that  the  award  should  be  made  by  the 
respective  presidents  for  the  time  being  of  tiie  Linnean,  Chemical  and 
Pharmaceutical  Societies  and  of  the  Britisli  Pharmaceutical  Conference, 
together  with  one  pharmaceutical  chemist,  who  should,  prior  to  each 
award,  be  nominated  by  the  last-named  two  presidents. 
The  medal  has,  on  this  occasion,  with  complete  accord  been  awarded  to 
Professor  FKickiger,  of  Strasburg,  and  I  am  sure  that  it  will  givfe  general 
satisfaction  that  the  valuable  labors  of  such  a  man  as  FKickiger,  coadjutor 
with  Daniel  Hanbury  in  the  Pharmacograi)hia,  have  received  recognition 
in  the  award  of  the  first  Hanbury  Medal.  The  only  alloy  to  this  pleasure 
will  be  to  find  that  Professor  Pliickiger's  state  of  health  prevents  his  being 
present  to  receive  it. 
Dr.  Brunnengraber,  President  of  the  German  Pharmaceutical  Society, 
received  the  medal  on  behalf  of  Prof.  Fliickiger,  and  expressed  his  thanks 
in  feeling  words.  The  father  of  Daniel  Hanlairy,  Mr.  Daniel  Bell  Hanbury^ 
was  present,  and,  after  expressing  his  heartfelt  satisfaction,  he  left  the 
room,  all  the  members  of  the  Congress  standing  up  while  he  did  so. 
The  President  of  the  Congress  having  resumed  the  chair,  Mr.  Carteighe,. 
on  behalf  of  the  officers  of  the  Congress,  submitted  the  following  resolu- 
tion with  regard  to  the  revision  of  the  Pharmacopoeia,  which  practically 
consisted  of  Dr.  Brunnengraber's  paper : 
That  in  the  opinion  of  the  Fifth  International  Congress,  meeting  in 
London,  it  is  the  duty  of  all  pharmacists  to  urge  that  in  the  future  revision 
of  the  National  Pharmacopoeia  it  is  necessary  that  there  should  be  a  per- 
manent connnittee  or  commission,  comprising  among  its  members  the 
largest  possible  number  of  pharmacists.  It  should  be  the  duty  of  this 
commission,  during  the  j^eriods  between  the  publication  of  the  successive 
editions,  to  investigate  such  new  drugs  as  make  their  appearance  in  the 
drug  market,  in  order  to  determine  the  characteristics  of  their  genuineness, 
and,  at  the  same  time,  to  submit  the  formulae  given  in  the  Pharmacopoeia 
to  a  continuous  examination.  The  results  of  this  work  should  be  brought 
to  the  knowledge  of  those  interested,  in  an  appropriate  manner,  by  publi- 
cation before  the  final  promulgation  of  that  work. 
The  resolution  was  carried  unanimously. 
A  paper  on  PharmaGopoeial  Nomeyiclature  was  read  by  Oscar  Oldberg^ 
New  York,  containing  the  following  propositions  : 
(1)  .  That  the  Berzelian  system  of  chemical  nomenclature,  as  illustrated 
in  a  general  way  by  the  pharinacopoeias  of  the  Scandinavian  countries,. 
France  and  Spain,  etc.,  be  adopted. 
(2)  .  That  in  naming  each  chemical  respectively,  that  part  of  the  name 
which  refers  to  the  base  shall  be  in  the  adjective  form,  and  placed 
before  the  other  so  as  to  combine  alphabetical  order  with  systematic 
classification. 
(3)  .  That  the  Latin  names  of  alkaloids  shall  have  the  termination  "-ina.'^ 
(4)  .  That  the  Latin  names  of  glucosides  and  other  neutral  principles 
shall  have  the  termination  "-inum." 
(5)  .  That  the  term  setheroleum  be  adopted  to  designate  volatile  oil. 
(6)  .  That  in  naming  solutions,  tinctures,  extracts  and  other  pharma- 
ceutical preparations  the  most  important  constituent  be  named  in  each 
